Mark M. Pomerantz

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 27 papers. Top paper: “Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States”.

Pain and Its Association with Survival for Black and White Individuals with Advanced Prostate Cancer in the United States

Cancer Research Communications(2023)10.1158/2767-9764.crc-23-0446

N/A

0.414DataRank · unranked

8 citations

Natalie Slopen, Hannah D. McManus, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain +24 more

Allele-Specific QTL Fine Mapping with PLASMA

The American Journal of Human Genetics(2020)10.1016/j.ajhg.2019.12.011

N/A

0DataRank · unranked

18 citations

Anamay Shetty, Edward O’Connor, Connor Bell, Mark M. Pomerantz, Matthew L. Freedman +2 more

Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

Molecular Cancer Research(2020)10.1158/1541-7786.mcr-20-0548

N/A

0DataRank · unranked

45 citations

Svitlana Tyekucheva, Jacob Rosenthal, Habiba El Fandy, Ryan Carelli, Stephanie Borgstein +13 more

Subtype Heterogeneity and Epigenetic Convergence in Neuroendocrine Prostate Cancer

(2020)10.1101/2020.09.13.291328

N/A

0DataRank · unranked

21 citations

Yingtian Xie, Alba Font‐Tello, Klothilda Lim, Sudeepa Syamala, Xintao Qiu +30 more

Integrative Molecular Characterization of Sarcomatoid and Rhabdoid Renal Cell Carcinoma Reveals Determinants of Poor Prognosis and Response to Immune Checkpoint Inhibitors

bioRxiv (Cold Spring Harbor Laboratory)(2020)10.1101/2020.05.28.121806

N/A

0DataRank · unranked

3 citations

David A. Braun, Sachet A. Shukla, Wenting Pan, Xīn Gào, Yue Hou +47 more

EZH2 inhibition activates a dsRNA–STING–interferon stress axis that potentiates response to PD-1 checkpoint blockade in prostate cancer

Nature Cancer(2021)10.1038/s43018-021-00185-w

N/A

0DataRank · unranked

241 citations

Anjali V. Sheahan, Deborah L. Burkhart, Sylvan C. Baca, Nadia Boufaied, Yin Liu +32 more

Reprogramming of the FOXA1 cistrome in treatment-emergent neuroendocrine prostate cancer

Nature Communications(2021)10.1038/s41467-021-22139-7

N/A

0DataRank · unranked

171 citations

David Y. Takeda, Ji-Heui Seo, Justin H. Hwang, Sheng-Yu Ku, Rand Arafeh +36 more

Integrative molecular characterization of sarcomatoid and rhabdoid renal cell carcinoma

Nature Communications(2021)10.1038/s41467-021-21068-9

N/A

0DataRank · unranked

169 citations

David A. Braun, Sachet A. Shukla, Wenting Pan, Xīn Gào, Yue Hou +48 more

Subtype heterogeneity and epigenetic convergence in neuroendocrine prostate cancer

Nature Communications(2021)10.1038/s41467-021-26042-z

N/A

0DataRank · unranked

163 citations

Yingtian Xie, Alba Font‐Tello, Klothilda Lim, Sudeepa Syamala, Xintao Qiu +33 more

Androgen receptor and MYC equilibration centralizes on developmental super-enhancer

Nature Communications(2021)10.1038/s41467-021-27077-y

N/A

0DataRank · unranked

80 citations

Yiming Wu, Mannan Nouri, Sándor Spisák, Joshua W. Russo, Adam G. Sowalsky +11 more

Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanisms

The American Journal of Human Genetics(2021)10.1016/j.ajhg.2021.09.008

N/A

0DataRank · unranked

11 citations

Ji-Heui Seo, Connor Bell, Edward O’Connor, Mark M. Pomerantz, Matthew L. Freedman +2 more

Allele-specific epigenetic activity in prostate cancer and normal prostate tissue implicates prostate cancer risk mechanisms

bioRxiv (Cold Spring Harbor Laboratory)(2021)10.1101/2021.06.02.446619

N/A

0DataRank · unranked

2 citations

Ji-Heui Seo, Connor Bell, Edward O’Connor, Mark M. Pomerantz, Matthew L. Freedman +2 more

MYC drives aggressive prostate cancer by disrupting transcriptional pause release at androgen receptor targets

Nature Communications(2022)10.1038/s41467-022-30257-z

N/A

0DataRank · unranked

160 citations

Nadia Boufaied, Tarek Hallal, Avery Feit, Anna de Polo, Adrienne Luoma +30 more

The Prostate Cancer Androgen Receptor Cistrome in African American Men Associates with Upregulation of Lipid Metabolism and Immune Response

Cancer Research(2022)10.1158/0008-5472.can-21-3552

N/A

0DataRank · unranked

40 citations

Elio Adib, Sarah Abou Alaiwi, Amit K. Dash, Jin Na Shin, Dallin Lowder +27 more

Clonal hematopoiesis and risk of prostate cancer in large samples of European ancestry men

Human Molecular Genetics(2022)10.1093/hmg/ddac214

N/A

0DataRank · unranked

11 citations

Yili Xu, Yao Yu, Kevin T. Nead, Tae‐Beom Kim, Keren Xu +34 more

Response to supraphysiological testosterone is predicted by a distinct androgen receptor cistrome

JCI Insight(2022)10.1172/jci.insight.157164

N/A

0DataRank · unranked

19 citations

Lisha G. Brown, Jennifer L. Conner, Holly M. Nguyen, Nadia Boufaied, Sarah Abou Alaiwi +15 more

Germline determinants of the prostate tumor genome

bioRxiv (Cold Spring Harbor Laboratory)(2022)10.1101/2022.11.16.516773

N/A

0DataRank · unranked

0 citations

Jiapei Yuan, Tommer Schwarz, Julie Livingstone, Natalie S. Fox, Weerachai Jaratlerdsiri +36 more

Liquid biopsy epigenomic profiling for cancer subtyping

Nature Medicine(2023)10.1038/s41591-023-02605-z

N/A

0DataRank · unranked

121 citations

Ji-Heui Seo, Matthew P. Davidsohn, Brad Fortunato, Karl Semaan, Shahabbedin Sotudian +38 more

Epigenomic charting and functional annotation of risk loci in renal cell carcinoma

Nature Communications(2023)10.1038/s41467-023-35833-5

N/A

0DataRank · unranked

34 citations

Sarah Abou Alaiwi, Sylvan C. Baca, Elio Adib, Rosario I. Corona, Ji-Heui Seo +31 more

A biallelic multiple nucleotide length polymorphism explains functional causality at 5p15.33 prostate cancer risk locus

Nature Communications(2023)10.1038/s41467-023-40616-z

N/A

0DataRank · unranked

13 citations

Viktória Tisza, Pier Vitale Nuzzo, Ji-Heui Seo, Bálint Pataki, Dezső Ribli +20 more

Quality of life in the year after new diagnosis with advanced prostate cancer for Black and White individuals living in the US

Quality of Life Research(2023)10.1007/s11136-023-03468-0

N/A

0DataRank · unranked

9 citations

Natalie Slopen, Karen A. Autio, Alicia K. Morgans, Lawrence McSwain, Pedro C. Barata +18 more

Data from Metabolomics of Prostate Cancer Gleason Score in Tumor Tissue and Serum

(2023)10.1158/1541-7786.c.6545205.v1

N/A

0DataRank · unranked

0 citations

Svitlana Tyekucheva, Jacob Rosenthal, Habiba El Fandy, Ryan Carelli, Stephanie Borgstein +13 more

Randomized Phase II Study Evaluating the Addition of Pembrolizumab to Radium-223 in Metastatic Castration-resistant Prostate Cancer

Cancer Immunology Research(2024)10.1158/2326-6066.cir-22-0306

N/A

0DataRank · unranked

36 citations

Lucia Kwak, Alexander Cheung, Kathryn M. Allaire, Jaqueline Marquez, David D. Yang +21 more

Epigenomic signatures of sarcomatoid differentiation to guide the treatment of renal cell carcinoma

Cell Reports(2024)10.1016/j.celrep.2024.114350

N/A

0DataRank · unranked

29 citations

Karl Semaan, Marc Eid, Ji-Heui Seo, Simon Garinet, Matthew P. Davidsohn +34 more

Assessing the contribution of rare protein-coding germline variants to prostate cancer risk and severity in 37,184 cases

Nature Communications(2025)10.1038/s41467-025-56944-1

N/A

0DataRank · unranked

11 citations

Niedzica Camacho, Patrick R. Shea, Konrad H. Stopsack, Vijai Joseph, Oliver S. Burren +29 more

Germline Sequencing DNA Repair Genes in 5545 Men With Aggressive and Nonaggressive Prostate Cancer

JNCI Journal of the National Cancer Institute(2020)10.1093/jnci/djaa132

N/A

0DataRank · unranked

88 citations

Tokhir Dadaev, Edward J. Saunders, Xin Sheng, Peggy Wan, Loreall Pooler +25 more

Genetic Drivers of Quality of Life in Prostate Cancer: An Evaluation of Genetic Polymorphisms and Patient-reported Outcomes in the E3805 CHAARTED trial

European Urology Oncology(2025)10.1016/j.euo.2025.04.003

N/A

0DataRank · unranked

1 citations

Xiangying Chu, Charles J. Ryan, Arjun Gupta, Christopher J. Sweeney, David F. Jarrard +10 more